{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:54:28Z","timestamp":1776941668214,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00262-020-02673-x","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:09:31Z","timestamp":1595405371000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5736-5495","authenticated-orcid":false,"given":"Mustafa Zafer","family":"Temiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-5306","authenticated-orcid":false,"given":"Aykut","family":"Colakerol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-9734","authenticated-orcid":false,"given":"Ismail","family":"Ulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-3025","authenticated-orcid":false,"given":"Enes","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-5518","authenticated-orcid":false,"given":"Filip","family":"Paslanmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2951-5991","authenticated-orcid":false,"given":"Sergen","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-8828","authenticated-orcid":false,"given":"Emrah","family":"Yuruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0580-2144","authenticated-orcid":false,"given":"Engin","family":"Kandirali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8688-4772","authenticated-orcid":false,"given":"Atilla","family":"Semercioz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-0886","authenticated-orcid":false,"given":"Ahmet Yaser","family":"Muslumanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"publisher","first-page":"12891","DOI":"10.18632\/oncotarget.14179","volume":"8","author":"M Kang","year":"2017","unstructured":"Kang M, Jeong CW, Kwak C, Kim HH, Ku JH (2017) Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Oncotarget 8:12891\u201312901. https:\/\/doi.org\/10.18632\/oncotarget.14179","journal-title":"Oncotarget"},{"key":"2673_CR2","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y (2017) Bladder cancer. Nat Rev Dis Primers 3:17022. https:\/\/doi.org\/10.1038\/nrdp.2017.22","journal-title":"Nat Rev Dis Primers"},{"key":"2673_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","volume":"69","author":"TJ Arends","year":"2016","unstructured":"Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus calmette-guerin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol 69:1046\u20131052. https:\/\/doi.org\/10.1016\/j.eururo.2016.01.006","journal-title":"Eur Urol"},{"issue":"45","key":"2673_CR4","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.urolonc.2013.06.008","volume":"32","author":"R Nunez-Nateras","year":"2014","unstructured":"Nunez-Nateras R, Castle EP, Protheroe CA et al (2014) Predicting response to bacillus Calmette-Guerin (BCG) in patients with carcinoma in situ of the bladder. Urol Oncol 32(45):e23\u201330. https:\/\/doi.org\/10.1016\/j.urolonc.2013.06.008","journal-title":"Urol Oncol"},{"key":"2673_CR5","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.5489\/cuaj.1196","volume":"3","author":"AR Zlotta","year":"2009","unstructured":"Zlotta AR, Fleshner NE, Jewett MA (2009) The management of BCG failure in non-muscle-invasive bladder cancer: an update. Can Urol Assoc J 3:S199\u2013205","journal-title":"Can Urol Assoc J"},{"key":"2673_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","volume":"73","author":"AM Kamat","year":"2018","unstructured":"Kamat AM, Li R, O'Donnell MA et al (2018) Predicting response to intravesical bacillus Calmette-Guerin immunotherapy: are we there yet? A systematic review. Eur Urol 73:738\u2013748. https:\/\/doi.org\/10.1016\/j.eururo.2017.10.003","journal-title":"Eur Urol"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3389\/fimmu.2019.02639","volume":"10","author":"S Prakash Babu","year":"2019","unstructured":"Prakash Babu S, Narasimhan PB, Babu S (2019) Eosinophil polymorphonuclear leukocytes in TB: what we know so far. Front Immunol 10:2639. https:\/\/doi.org\/10.3389\/fimmu.2019.02639","journal-title":"Front Immunol"},{"key":"2673_CR8","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1128\/iai.68.5.2976-2978.2000","volume":"68","author":"J Kirman","year":"2000","unstructured":"Kirman J, Zakaria Z, McCoy K, Delahunt B, Le Gros G (2000) Role of eosinophils in the pathogenesis of Mycobacterium bovis BCG infection in gamma interferon receptor-deficient mice. Infect Immun 68:2976\u20132978. https:\/\/doi.org\/10.1128\/iai.68.5.2976-2978.2000","journal-title":"Infect Immun"},{"key":"2673_CR9","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1128\/IAI.59.9.3009-3014.1991","volume":"59","author":"AG Castro","year":"1991","unstructured":"Castro AG, Esaguy N, Macedo PM, Aguas AP, Silva MT (1991) Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils in vivo and are ingested by the attracted granulocytes. Infect Immun 59:3009\u20133014","journal-title":"Infect Immun"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/106689690501300203","volume":"13","author":"R Montironi","year":"2005","unstructured":"Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13:143\u2013153. https:\/\/doi.org\/10.1177\/106689690501300203","journal-title":"Int J Surg Pathol"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73:560\u2013569. https:\/\/doi.org\/10.1016\/j.eururo.2017.12.018","journal-title":"Eur Urol"},{"key":"2673_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fmed.2017.00051","volume":"4","author":"LK Johnston","year":"2017","unstructured":"Johnston LK, Bryce PJ (2017) Understanding interleukin 33 and its roles in eosinophil development. Front Med 4:51. https:\/\/doi.org\/10.3389\/fmed.2017.00051","journal-title":"Front Med"},{"key":"2673_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13:9\u201322. https:\/\/doi.org\/10.1038\/nri3341","journal-title":"Nat Rev Immunol"},{"key":"2673_CR14","doi-asserted-by":"publisher","first-page":"e1393134","DOI":"10.1080\/2162402X.2017.1393134","volume":"7","author":"G Varricchi","year":"2018","unstructured":"Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, Marone G, Schiavoni G (2018) Eosinophils: the unsung heroes in cancer? Oncoimmunology 7:e1393134. https:\/\/doi.org\/10.1080\/2162402X.2017.1393134","journal-title":"Oncoimmunology"},{"key":"2673_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.iac.2015.05.007","volume":"35","author":"BS Bochner","year":"2015","unstructured":"Bochner BS (2015) Novel therapies for eosinophilic disorders. Immunol Allergy Clin N Am 35:577\u2013598. https:\/\/doi.org\/10.1016\/j.iac.2015.05.007","journal-title":"Immunol Allergy Clin N Am"},{"key":"2673_CR16","doi-asserted-by":"publisher","first-page":"e1317420","DOI":"10.1080\/2162402X.2017.1317420","volume":"6","author":"V Lucarini","year":"2017","unstructured":"Lucarini V, Ziccheddu G, Macchia I et al (2017) IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils. Oncoimmunology 6:e1317420. https:\/\/doi.org\/10.1080\/2162402X.2017.1317420","journal-title":"Oncoimmunology"},{"key":"2673_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1165\/ajrcmb.17.1.2796","volume":"17","author":"T Horiuchi","year":"1997","unstructured":"Horiuchi T, Weller PF (1997) Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 17:70\u201377. https:\/\/doi.org\/10.1165\/ajrcmb.17.1.2796","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2673_CR18","doi-asserted-by":"publisher","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931\u201310934","journal-title":"J Biol Chem"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3109\/0284186X.2014.887857","volume":"53","author":"CL Andersen","year":"2014","unstructured":"Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, de Fine ON, Bjerrum OW (2014) Eosinophilia in routine blood samples as a biomarker for solid tumor development - a study based on the Copenhagen Primary Care Differential Count (CopDiff) Database. Acta Oncol 53:1245\u20131250. https:\/\/doi.org\/10.3109\/0284186X.2014.887857","journal-title":"Acta Oncol"},{"key":"2673_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1046\/j.1464-410X.2001.02394.x","volume":"88","author":"F Saint","year":"2001","unstructured":"Saint F, Patard JJ, Groux Muscatelli B, Lefrere Belda MA, Diez G, de Medina S, Abbou CC, Chopin DK (2001) Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment. BJU Int 88:602\u2013610","journal-title":"BJU Int"},{"key":"2673_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","volume":"66","author":"R Pichler","year":"2017","unstructured":"Pichler R, Gruenbacher G, Culig Z, Brunner A, Fuchs D, Fritz J, Gander H, Rahm A, Thurnher M (2017) Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer. Cancer Immunol Immunother CII 66:427\u2013440. https:\/\/doi.org\/10.1007\/s00262-016-1945-z","journal-title":"Cancer Immunol Immunother CII"},{"key":"2673_CR22","doi-asserted-by":"publisher","first-page":"857416","DOI":"10.1155\/2015\/857416","volume":"2015","author":"Y Miyata","year":"2015","unstructured":"Miyata Y, Sakai H (2015) Predictive markers for the recurrence of nonmuscle invasive bladder cancer treated with intravesical therapy. Dis Mark 2015:857416. https:\/\/doi.org\/10.1155\/2015\/857416","journal-title":"Dis Mark"},{"key":"2673_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","volume":"8","author":"NL Diny","year":"2017","unstructured":"Diny NL, Rose NR, Cihakova D (2017) Eosinophils in autoimmune diseases. Front Immunol 8:484. https:\/\/doi.org\/10.3389\/fimmu.2017.00484","journal-title":"Front Immunol"},{"key":"2673_CR24","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","volume":"134","author":"JM Caldwell","year":"2014","unstructured":"Caldwell JM, Collins MH, Stucke EM, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Rothenberg ME (2014) Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol 134:1114\u20131124. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.026","journal-title":"J Allergy Clin Immunol"},{"key":"2673_CR25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jcp.37.5.500","volume":"37","author":"D Lowe","year":"1984","unstructured":"Lowe D, Fletcher CD, Gower RL (1984) Tumour-associated eosinophilia in the bladder. J Clin Pathol 37:500\u2013502","journal-title":"J Clin Pathol"},{"key":"2673_CR26","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1182\/blood-2008-07-166595","volume":"113","author":"V Driss","year":"2009","unstructured":"Driss V, Legrand F, Hermann E et al (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113:3235\u20133244. https:\/\/doi.org\/10.1182\/blood-2008-07-166595","journal-title":"Blood"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/IAI.71.2.605-613.2003","volume":"71","author":"V Borelli","year":"2003","unstructured":"Borelli V, Vita F, Shankar S, Soranzo MR, Banfi E, Scialino G, Brochetta C, Zabucchi G (2003) Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun 71:605\u2013613","journal-title":"Infect Immun"},{"key":"2673_CR28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.eururo.2006.11.045","volume":"51","author":"S Siracusano","year":"2007","unstructured":"Siracusano S, Vita F, Abbate R, Ciciliato S, Borelli V, Bernabei M, Zabucchi G (2007) The role of granulocytes following intravesical BCG prophylaxis. Eur Urol 51:1589\u20131597. https:\/\/doi.org\/10.1016\/j.eururo.2006.11.045\u00a0(discussion 97\u201399)","journal-title":"Eur Urol"},{"key":"2673_CR29","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1164\/rccm.201807-1289LE","volume":"198","author":"HJ Durrington","year":"2018","unstructured":"Durrington HJ, Gioan-Tavernier GO, Maidstone RJ et al (2018) Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment. Am J Respir Crit Care Med 198:1578\u20131581. https:\/\/doi.org\/10.1164\/rccm.201807-1289LE","journal-title":"Am J Respir Crit Care Med"},{"key":"2673_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3109\/00365513.2011.602422","volume":"71","author":"HP Sennels","year":"2011","unstructured":"Sennels HP, Jorgensen HL, Hansen AL, Goetze JP, Fahrenkrug J (2011) Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Investig 71:532\u2013541. https:\/\/doi.org\/10.3109\/00365513.2011.602422","journal-title":"Scand J Clin Lab Investig"},{"key":"2673_CR31","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.2147\/COPD.S226783","volume":"14","author":"HX Wu","year":"2019","unstructured":"Wu HX, Zhuo KQ, Cheng DY (2019) Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis 14:3003\u20133015. https:\/\/doi.org\/10.2147\/COPD.S226783","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1183\/13993003.00055-2016","volume":"47","author":"ID Pavord","year":"2016","unstructured":"Pavord ID, Agusti A (2016) Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J 47:1299\u20131303. https:\/\/doi.org\/10.1183\/13993003.00055-2016","journal-title":"Eur Respir J"},{"key":"2673_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","volume":"5","author":"M Bafadhel","year":"2017","unstructured":"Bafadhel M, Pavord ID, Russell REK (2017) Eosinophils in COPD: just another biomarker? Lancet Respir Med 5:747\u2013759. https:\/\/doi.org\/10.1016\/S2213-2600(17)30217-5","journal-title":"Lancet Respir Med"},{"key":"2673_CR34","doi-asserted-by":"publisher","first-page":"33719","DOI":"10.18632\/oncotarget.26120","volume":"9","author":"CE Onesti","year":"2018","unstructured":"Onesti CE, Josse C, Poncin A, Freres P, Poulet C, Bours V, Jerusalem G (2018) Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative\/HER2-positive breast cancer patients undergoing neoadjuvant treatment. Oncotarget 9:33719\u201333733. https:\/\/doi.org\/10.18632\/oncotarget.26120","journal-title":"Oncotarget"},{"key":"2673_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2217\/imt-2016-0138","volume":"9","author":"A Moreira","year":"2017","unstructured":"Moreira A, Leisgang W, Schuler G, Heinzerling L (2017) Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy. Immunotherapy 9:115\u2013121. https:\/\/doi.org\/10.2217\/imt-2016-0138","journal-title":"Immunotherapy"},{"key":"2673_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fonc.2018.00078","volume":"8","author":"JL Sylman","year":"2018","unstructured":"Sylman JL, Mitrugno A, Atallah M et al (2018) The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis. Front Oncol 8:78. https:\/\/doi.org\/10.3389\/fonc.2018.00078","journal-title":"Front Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T23:36:50Z","timestamp":1626910610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02673-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}